<DOC>
	<DOCNO>NCT00860405</DOCNO>
	<brief_summary>This study compare clinical efficacy safety Voluven® Human Albumin elective open-heart surgery pediatric patient .</brief_summary>
	<brief_title>Voluven® Paediatric Patients</brief_title>
	<detailed_description>In past , human albumin widely accept therapeutic `` gold standard '' paediatric volume replacement therapy physiological hypoproteinemia newborn infant . In adult patient , artificial colloid hydroxyethyl starch replace human albumin first choice many setting . This study compare clinical efficacy safety HES 130/0.4 ( 6 % ) normal saline vs. HSA 50g/L volume replacement therapy elective open-heart surgery paediatric patient . The hypothesis study demonstrate HES 130/0.4 ( 6 % ) HSA 50g/L equivalent regard efficacy provide comparable safety elective open-heart surgery paediatric patient 2 12 year age .</detailed_description>
	<mesh_term>Hydroxyethyl Starch Derivatives</mesh_term>
	<criteria>Male female paediatric patient , 2 12 year age , suffer congenital heartdisease undergo elective openheart surgery require ECC ; Signed parental write informed consent patient assent achievable Known contraindication schedule concomitant medication ; Total ECC volume &lt; 400 mL ; ASA &gt; III</criteria>
	<gender>All</gender>
	<minimum_age>2 Years</minimum_age>
	<maximum_age>12 Years</maximum_age>
	<verification_date>October 2011</verification_date>
</DOC>